Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China
- PMID: 23322152
- PMCID: PMC3731800
- DOI: 10.1093/carcin/bgt007
Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China
Abstract
Qidong City, China, has had high liver cancer incidence from endemic hepatitis B virus (HBV) infection and dietary exposure to aflatoxin. Based on etiologic studies, we began interventions in 1980 to reduce dietary aflatoxin and initiate neonatal HBV vaccination. We studied trends in liver cancer incidence rates in the 1.1 million inhabitants of Qidong and examined trends in aflatoxin exposure, staple food consumption, HBV infection markers and annual income. Aflatoxin exposure declined greatly in association with economic reform, increased earnings and educational programs to shift staple food consumption in the total population from moldy corn to fresh rice. A controlled neonatal HBV vaccination trial began in 1983 and ended in November, 1990, when vaccination was expanded to all newborns. Liver cancer incidence fell dramatically in young adults. Compared with 1980-83, the age-specific liver cancer incidence rates in 2005-08 significantly decreased 14-fold at ages 20-24, 9-fold at ages 25-29, 4-fold at ages 30-34, 1.5-fold at ages 35-39, 1.2-fold at ages 40-44 and 1.4-fold at ages 45-49, but increased at older ages. The 14-fold reduction at ages 20-24 might reflect the combined effects of reduced aflatoxin exposure and partial neonatal HBV vaccination. Decrease incidence in age groups >25 years could mainly be attributable to rapid aflatoxin reduction. Compared with 1980-83, liver cancer incidence in 1990-93 significantly decreased 3.4-fold at ages 20-24, and 1.9-fold at ages 25-29 when the first vaccinees were <11 years old.
Figures
Similar articles
-
Reduced aflatoxin exposure presages decline in liver cancer mortality in an endemic region of China.Cancer Prev Res (Phila). 2013 Oct;6(10):1038-45. doi: 10.1158/1940-6207.CAPR-13-0168. Epub 2013 Aug 20. Cancer Prev Res (Phila). 2013. PMID: 23963804 Free PMC article.
-
Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China.Cancer Epidemiol Biomarkers Prev. 1996 Apr;5(4):253-61. Cancer Epidemiol Biomarkers Prev. 1996. PMID: 8722216
-
[Primary prevention by hepatitis B vaccine on liver cancer in high incidence area of China].Zhonghua Yu Fang Yi Xue Za Zhi. 2018 Apr 6;52(4):402-408. doi: 10.3760/cma.j.issn.0253-9624.2018.04.013. Zhonghua Yu Fang Yi Xue Za Zhi. 2018. PMID: 29614608 Chinese.
-
[Hepatitis B vaccine and liver cancer].Bull Cancer. 2021 Jan;108(1):90-101. doi: 10.1016/j.bulcan.2020.10.014. Epub 2020 Dec 25. Bull Cancer. 2021. PMID: 33358507 Review. French.
-
Population attributable risk of aflatoxin-related liver cancer: systematic review and meta-analysis.Eur J Cancer. 2012 Sep;48(14):2125-36. doi: 10.1016/j.ejca.2012.02.009. Epub 2012 Mar 8. Eur J Cancer. 2012. PMID: 22405700 Free PMC article. Review.
Cited by
-
Burden of gastrointestinal cancers among adolescent and young adults in Asia-Pacific region: trends from 1990 to 2019 and future predictions to 2044.Ann Med. 2024 Dec;56(1):2427367. doi: 10.1080/07853890.2024.2427367. Epub 2024 Nov 17. Ann Med. 2024. PMID: 39551644 Free PMC article.
-
Trends in Cancer Incidence and Potential Associated Factors in China.JAMA Netw Open. 2024 Oct 1;7(10):e2440381. doi: 10.1001/jamanetworkopen.2024.40381. JAMA Netw Open. 2024. PMID: 39432306 Free PMC article.
-
The Need for an Alternative Health Claim Process for Foods Based on Both Nutrient and Contaminant Profiles.Curr Dev Nutr. 2024 Apr 25;8(6):103764. doi: 10.1016/j.cdnut.2024.103764. eCollection 2024 Jun. Curr Dev Nutr. 2024. PMID: 38813480 Free PMC article.
-
Cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors.Sci China Life Sci. 2024 Jan;67(1):122-131. doi: 10.1007/s11427-023-2423-1. Epub 2023 Sep 21. Sci China Life Sci. 2024. PMID: 37755589
-
Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes.Cancer Rep (Hoboken). 2023 Sep;6 Suppl 1(Suppl 1):e1821. doi: 10.1002/cnr2.1821. Epub 2023 Jun 21. Cancer Rep (Hoboken). 2023. PMID: 37344125 Free PMC article. Review.
References
-
- Jemal A., et al. (2011). Global cancer statistics. CA. Cancer J. Clin., 61, 69–90 - PubMed
-
- Chen J.G., et al. (2006). Trends in the incidence of cancer in Qidong, China, 1978–2002. Int. J. Cancer., 119, 1447–1454 - PubMed
-
- Xia Q.J., aka Hsia C.C., et al. (1984). Liver cell cancer in the young and adolescent and its relation to hepatitis B virus (HBV). Chin. J. Oncol., 6, 413–416 - PubMed
-
- Lu J., et al. (1983). Matched prospective study of primary hepatocellular carcinoma in chronic carriers of HBsAg. Chin. J. Oncol., 5, 406–408 - PubMed
-
- Sun T., et al. (1984). Carcinogenesis and prevention strategy of liver cancer in areas of prevalence. In Mak T.W. et al. (eds) Cellular and Molecular Biology of Neoplasia., Alan R. Liss Inc. New York, USA: pp. 39–44 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical